Bokhove Marcel, Sadat Al Hosseini Hamed, Saito Takako, Dioguardi Elisa, Gegenschatz-Schmid Katharina, Nishimura Kaoru, Raj Isha, de Sanctis Daniele, Han Ling, Jovine Luca
Karolinska Institutet, Department of Biosciences and Nutrition & Center for Innovative Medicine, Huddinge, Sweden.
ESRF - The European Synchrotron, Grenoble 38000, France.
J Struct Biol. 2016 Apr;194(1):1-7. doi: 10.1016/j.jsb.2016.01.016. Epub 2016 Feb 3.
We present a strategy to obtain milligrams of highly post-translationally modified eukaryotic proteins, transiently expressed in mammalian cells as rigid or cleavable fusions with a mammalianized version of bacterial maltose-binding protein (mMBP). This variant was engineered to combine mutations that enhance MBP solubility and affinity purification, as well as provide crystal-packing interactions for increased crystallizability. Using this cell type-independent approach, we could increase the expression of secreted and intracellular human proteins up to 200-fold. By molecular replacement with MBP, we readily determined five novel high-resolution structures of rigid fusions of targets that otherwise defied crystallization.
我们提出了一种策略,可获得毫克级高度翻译后修饰的真核蛋白质,这些蛋白质在哺乳动物细胞中作为与细菌麦芽糖结合蛋白(mMBP)的哺乳动物化形式的刚性或可切割融合蛋白瞬时表达。该变体经过工程改造,结合了增强MBP溶解性和亲和纯化的突变,并提供晶体堆积相互作用以提高结晶性。使用这种不依赖细胞类型的方法,我们可以将分泌型和细胞内人类蛋白质的表达提高多达200倍。通过用MBP进行分子置换,我们轻松确定了五个原本难以结晶的靶标刚性融合体的新型高分辨率结构。